1-4 of 4
A Piga
Close
Sort by
Journal Articles

Long-Term Treatment with the Once-Daily Oral Iron Chelator Deferasirox (Exjadereg], ICL670) Is Effective and Generally Well Tolerated in Pediatric Patients.

A. Piga, M. Bejaoui, Y. Kilinc, S. Perrotta, E. Vichinsky, C. Arrowsmith-Bensasson, E. Glimm, D. Alberti
Journal: Blood
Blood (2006) 108 (11): 1781.
https://doi.org/10.1182/blood.V108.11.1781.1781
Published: 2006
Journal Articles

Summary of Long-Term Renal Safety Data in Transfused Patients with Secondary Iron Overload Receiving Deferasirox (Exjade®, ICL670).

W. Bennett, C. Ponticelli, A. Piga, A. Kattamis, E. Glimm, J. Ford
Journal: Blood
Blood (2006) 108 (11): 3816.
https://doi.org/10.1182/blood.V108.11.3816.3816
Published: 2006
Journal Articles

Comparison of LIC Obtained from Biopsy, BLS and R 2 -MRI in Iron Overloaded Patients with β-Thalassemia, Treated with Deferasirox (Exjade®, ICL670).

A. Piga, R. Fischer, P. Harmatz, T. G. St. Pierre, F. Longo, E. Fung, R. Engelhardt, S. Perrotta, R. Galanello, M. Capra, E. Vichinsky, G. Janka-Schaub, G. Masera, P. Cianciulli, T. Coates, G. Janssen, M. Jeng, M. E. Lai, G. Salles, P. Cole, D. Alberti, G. Rosenkranz, H. Opitz
Journal: Blood
Blood (2005) 106 (11): 2689.
https://doi.org/10.1182/blood.V106.11.2689.2689
Published: 2005
Journal Articles

Deletion delta-thalassemia: the 7.2 kb deletion of Corfu delta beta- thalassemia in a non-beta-thalassemia chromosome [letter]

R Galanello, MA Melis, A Podda, M Monne, L Perseu, G Loudianos, A Cao, M Pirastu, A Piga
Journal: Blood
Blood (1990) 75 (8): 1747–1749.
https://doi.org/10.1182/blood.V75.8.1747.1747
Published: 1990